The ADOPTION study, conducted in a cohort of patients showing early fluctuations similar to our patients, showed a trend for greater improvements in Part III with opicapone (−3.4) compared with levodopa at 100 mg (−2.5) in the first month and a greater reduction in the percentage of OFF time ( p = 0.0015) [ 19 ].
← all excerpts
Real-World Use of COMT Inhibitors in the Management of Patients with Parkinson's Disease in Spain Who Present Early Motor Fluctuations: Interim Results from the REONPARK Study.
1
—
—